In a side-by-side comparison with the positive control TNFRII-Fc, TNFRII-Trimer exhibited also statistically more potent effect by nearly 2 basic points in arthritis index in the treatment of established CIA than TNFRII-Fc (Fig. 6a). This evidence concerns the gene TNFRSF1B and arthritic joint disease.